B12 deficiency is one of the more frequently reported nutritional gaps in long-term GLP-1 users, manifesting as fatigue, brain fog, and peripheral neuropathy
Constipation , diarrhea, and bloating round out the gastrointestinal effects that most users experience to some degree
The ADA and Kidney Disease Improving Global Outcomes (KDIGO) guidelines recommend using SGLT2is with demonstrated benefit in reducing CKD progression and CV events in individuals who have type 2 diabetes with an eGFR of 20 mL/min/1.73 m 2 (KDIGO, 2022
If you're trying to cut back on drinking, you can start with evidence-based medication and behavioral support now, without waiting for future GLP-1 approvals
For a 50-unit draw, that's 2.5 units, or 0.025 mL
After determining eligibility, medical supervision ensures treatments are both safe and effective